Clinical Trials Browser

Withdrawn × Hydralazine × Clear all

NCT02446652 2025-05-29

Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer

Phase 3 Withdrawn

Uterine Cervical Neoplasms

NCT00575640 2015-03-04

Hydralazine as a Demethylating Agent in Rectal Cancer

Phase 1/2 Withdrawn

Gastrointestinal

Rectal Neoplasms

NCT00575978 2015-03-04

Hydralazine as Demethylating Agent in Breast Cancer

Phase 1/2 Withdrawn

Breast Neoplasms